Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
13.77
+0.01 (0.07%)
At close: Sep 2, 2026, 4:00 PM EDT
13.76
-0.01 (-0.07%)
After-hours: Sep 2, 2026, 7:30 PM EDT
Organon & Co. Employees
Organon & Co. had 10,000 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
10,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$612,700
Profits / Employee
$20,900
Market Cap
3.62B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 10,000 | 0 | - |
| Dec 31, 2024 | 10,000 | 0 | - |
| Dec 31, 2023 | 10,000 | 0 | - |
| Dec 31, 2022 | 10,000 | 700 | 7.53% |
| Dec 31, 2021 | 9,300 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 95,100 |
| Pfizer | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| GSK plc | 66,841 |
| Bristol-Myers Squibb Company | 32,500 |
| Amgen | 31,500 |
| Grifols | 25,247 |
OGN News
- 6 days ago - National Can-RISE Study to Help Close Critical Gaps in Menopause Research - GlobeNewsWire
- 22 days ago - Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability - Business Wire
- 4 weeks ago - Organon & Co. Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Organon Announces Quarterly Dividend - Business Wire
- 5 weeks ago - New Analysis of Phase 3 Pooled Data for Organon's VTAMA® (tapinarof) cream, 1%, Demonstrates Early, Consistent Improvements in Atopic Dermatitis Patients Across Pediatric Age Groups and in Adults1 - Business Wire
- 5 weeks ago - Organon & Co. Transcript: EGM 2026 - Transcripts
- 6 weeks ago - Organon & Co. Proxy statement: Proxy filing - Filings
- 6 weeks ago - Organon to Report Second Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing - Business Wire